Aquestive Therapeutics (AQST) Return on Equity (2018 - 2025)
Historic Return on Equity for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 1.8%.
- Aquestive Therapeutics' Return on Equity rose 9300.0% to 1.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.8%, marking a year-over-year increase of 9300.0%. This contributed to the annual value of 0.53% for FY2024, which is 4600.0% up from last year.
- Latest data reveals that Aquestive Therapeutics reported Return on Equity of 1.8% as of Q3 2025, which was up 9300.0% from 0.97% recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Return on Equity registered a high of 1.8% during Q3 2025, and its lowest value of 0.08% during Q4 2023.
- In the last 5 years, Aquestive Therapeutics' Return on Equity had a median value of 0.79% in 2022 and averaged 0.75%.
- In the last 5 years, Aquestive Therapeutics' Return on Equity crashed by -39700bps in 2021 and then skyrocketed by 9300bps in 2025.
- Aquestive Therapeutics' Return on Equity (Quarter) stood at 0.99% in 2021, then plummeted by -51bps to 0.48% in 2022, then plummeted by -84bps to 0.08% in 2023, then surged by 1012bps to 0.84% in 2024, then soared by 115bps to 1.8% in 2025.
- Its Return on Equity was 1.8% in Q3 2025, compared to 0.97% in Q2 2025 and 0.9% in Q1 2025.